Studies on central and peripheral noradrenaline neurons using a new dopamine-β-hydroxylase inhibitor
Authors:
- H. CorrodiHCH. Corrodi
- K. FuxeKFK. Fuxe
- B. HambergerBHB. Hamberger
- Å. LjungdahlÅLÅ. Ljungdahl
- 1 October 1970
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 12 (2) , 145-155
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Behavioral and biochemical effects ofl-DOPA after peripheral decarboxylase inhibitionBrain Research, 1969
- The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibitionLife Sciences, 1967
- Failure of dopamine to accumulate in central noradrenaline neurons after depletion with diethyldithiocarbamateJournal of Pharmacy and Pharmacology, 1967
- Effect of some drugs on central monoamine nerve terminals lacking nerve impulse flowEuropean Journal of Pharmacology, 1967
- Ascending Monoamine Neurons to the Telencephalon and DiencephalonActa Physiologica Scandinavica, 1966
- Effects of tyrosine hydroxylase inhibition on the amine levels of central monoamine neuronsLife Sciences, 1966
- Histochemical amd biochemical effects of diethyldithiocarbamate on tissue catecholaminesJournal of Pharmacy and Pharmacology, 1966
- Inhibition of dopamine-β-oxidase by dietbyldithiocarbamateJournal of Pharmacy and Pharmacology, 1965
- In‐Vivo Decarboxylation of α‐Methyl DOPA and α‐Methyl MetatyrosineActa Physiologica Scandinavica, 1962
- A Method for the Fluorimetric Determination of Adrenaline and Noradrenaline in Tissues.1Acta Physiologica Scandinavica, 1958